Clinical Trial Update: Managed Access Program (MAP) for Patients Diagnosed With Secondary Progressive Multiple Sclerosis With Active Disease

View source ↗

Summary

The clinical trial update confirms that the Novartis-sponsored Managed Access Program for patients with secondary progressive multiple sclerosis with active dis…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis
• Progressive Multiple Sclerosis

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Multiple Sclerosis | Status: NO_LONGER_AVAILABLE